Home

BioXcel Therapeutics, Inc. - Common Stock (BTAI)

2.9567
+0.2567 (9.51%)

Bioxcel Therapeutics is a biopharmaceutical company focused on innovative drug development to address unmet medical needs in the fields of neurology and psychiatry

Utilizing its proprietary artificial intelligence platform, the company aims to identify and advance novel therapeutics that can improve patient outcomes in challenging conditions such as agitation in Alzheimer's patients and cancer-related symptoms. Bioxcel's approach integrates data-driven decision-making and clinical research to bring forth potential treatments that enhance the quality of life for patients dealing with complex health issues.

SummaryNewsPress ReleasesChartHistoricalFAQ
Which stocks have an unusual volume on Wednesday?chartmill.com
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the stocks with an unusual volume in today's session.
Via Chartmill · March 5, 2025
These stocks that are showing activity before the opening bell on Wednesday.chartmill.com
The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via Chartmill · March 5, 2025
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.chartmill.com
Curious to know what's happening on the US markets one hour before the close of the markets on Tuesday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · March 4, 2025
Top movers analysis in the middle of the day on 2025-03-04: top gainers and losers in today's session.chartmill.com
Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · March 4, 2025
What's Next: BioXcel Therapeutics's Earnings Previewbenzinga.com
Via Benzinga · November 13, 2024
Here are the top movers in Monday's session.chartmill.com
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Via Chartmill · March 3, 2025
Most active stocks in Monday's sessionchartmill.com
These stocks are making the most noise in today's session. Stay tuned for the latest updates!
Via Chartmill · March 3, 2025
Let's take a look at the stocks that are in motion in today's session.chartmill.com
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Via Chartmill · March 3, 2025
BioXcel Shares Are Up Today: What's Going On?benzinga.com
BioXcel Therapeutics, Inc. (NASDAQBTAI) shares are trading higher Monday following news that the U.S. Food and Drug Administration (FDA) has concluded its inspection of a site involved in the company's Phase 3 TRANQUILITY II trial.
Via Benzinga · March 3, 2025
Check out the stocks that are attracting the most attention and driving market activity.chartmill.com
Let's have a look at what is happening on the US markets on Friday. Below you can find the most active stocks in today's session.
Via Chartmill · February 28, 2025
Friday's session: top gainers and loserschartmill.com
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · February 28, 2025
Get insights into the top gainers and losers of Friday's pre-market session.chartmill.com
Discover the top movers in Friday's pre-market session and stay informed about market dynamics.
Via Chartmill · February 28, 2025
Which stocks are experiencing notable movement on Monday?chartmill.com
Curious to know what's happening on the US markets one hour before the close of the markets on Monday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · February 10, 2025
Let's have a look at the top gainers and losers in the middle of the day of today's session.chartmill.com
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Via Chartmill · February 10, 2025
The market is filled with gapping stocks in Monday's session.chartmill.com
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps.
Via Chartmill · February 10, 2025
Wondering what's happening in today's after-hours session?chartmill.com
The US market regular session of Friday is over, let's have a look at the top gainers and losers in the after hours session today.
Via Chartmill · February 7, 2025
Which stocks are moving on Thursday?chartmill.com
Let's have a look at what is happening on the US markets one hour before the close of the markets on Thursday. Below you can find the top gainers and losers in today's session.
Via Chartmill · February 6, 2025
Thursday's session: top gainers and loserschartmill.com
Curious to know what's happening on the US markets in the middle of the day on Thursday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · February 6, 2025
Thursday's session: gap up and gap down stockschartmill.com
The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Via Chartmill · February 6, 2025
What's going on in today's after hours sessionchartmill.com
The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Via Chartmill · February 4, 2025
Why Twilio Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · January 24, 2025
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · November 22, 2024
BTAI Stock Earnings: BioXcel Therapeutics Beats EPS, Beats Revenue for Q2 2024investorplace.com
BTAI stock results show that BioXcel Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 6, 2024
Earnings Scheduled For November 14, 2024benzinga.com
Via Benzinga · November 14, 2024
BioXcel Therapeutics' Approved Drug For Bipolar Disorders/Schizophrenia Shows No Evidence Of Worsening Or Withdrawal In Post-Marketing Studybenzinga.com
BioXcel Therapeutics shares topline results from an Igalmi (dexmedetomidine) sublingual film study. The 180 mcg dose demonstrated favorable safety and efficacy in reducing agitation symptoms.
Via Benzinga · June 25, 2024